Shopping cart
Your cart empty!
Mounjaro 5mg Injection, an innovative medication, contains Tirzepatide as its active ingredient. It belongs to the pharmacological class of GLP-1 and GIP receptor agonists, a first-in-class dual-incretin therapy.
Mounjaro Injection, an innovative medication, contains Tirzepatide as its active ingredient. It belongs to the pharmacological class of GLP-1 and GIP receptor agonists, a first-in-class dual-incretin therapy. This injection is primarily used to manage blood sugar levels in adults with type 2 diabetes mellitus who are unable to achieve adequate glycemic control through oral antidiabetic medications, diet, and exercise.
By mimicking the action of two natural incretin hormones—GLP-1 and GIP—Mounjaro enhances glucose-dependent insulin secretion, suppresses glucagon release, slows gastric emptying, and reduces appetite. These mechanisms help lower post-meal blood sugar levels and improve overall metabolic control.